scholarly journals Binding ofSalmonella‐Specific Antibody Facilitates Specific T Cell Responses via Augmentation of Bacterial Uptake and Induction of Apoptosis in Macrophages

2010 ◽  
Vol 201 (1) ◽  
pp. 62-70 ◽  
Author(s):  
Masahiro Eguchi ◽  
Yuji Kikuchi
2011 ◽  
Vol 34 (9) ◽  
pp. 629-640 ◽  
Author(s):  
Anders Elm Pedersen ◽  
Anette Stryhn ◽  
Sune Justesen ◽  
Mikkel Harndahl ◽  
Susanne Rasmussen ◽  
...  

2007 ◽  
Vol 7 (4) ◽  
pp. 186 ◽  
Author(s):  
Su-Hyung Park ◽  
Jun Chang ◽  
Se-Hwan Yang ◽  
Hye-Ju Kim ◽  
Hyun-Hee Kwak ◽  
...  

2016 ◽  
Vol 90 (9) ◽  
pp. 4278-4288 ◽  
Author(s):  
Nicholas M. Provine ◽  
Alexander Badamchi-Zadeh ◽  
Christine A. Bricault ◽  
Pablo Penaloza-MacMaster ◽  
Rafael A. Larocca ◽  
...  

ABSTRACTWe have recently demonstrated that CD4+T cell help is required at the time of adenovirus (Ad) vector immunization for the development of functional CD8+T cell responses, but the temporal requirement for CD4+T cell help for the induction of antibody responses remains unclear. Here we demonstrate that induction of antibody responses in C57BL/6 mice can occur at a time displaced from the time of Ad vector immunization by depletion of CD4+T cells. Transient depletion of CD4+T cells at the time of immunization delays the development of antigen-specific antibody responses but does not permanently impair their development or induce tolerance against the transgene. Upon CD4+T cell recovery, transgene-specific serum IgG antibody titers develop and reach a concentration equivalent to that in undepleted control animals. These delayed antibody responses exhibit no functional defects with regard to isotype, functional avidity, expansion after boosting immunization, or the capacity to neutralize a simian immunodeficiency virus (SIV) Env-expressing pseudovirus. The development of this delayed transgene-specific antibody response is temporally linked to the expansion ofde novoantigen-specific CD4+T cell responses, which develop after transient depletion of CD4+T cells. These data demonstrate that functional vaccine-elicited antibody responses can be induced even if CD4+T cell help is provided at a time markedly separated from the time of vaccination.IMPORTANCECD4+T cells have a critical role in providing positive help signals to B cells, which promote robust antibody responses. The paradigm is that helper signals must be provided immediately upon antigen exposure, and their absence results in tolerance against the antigen. Here we demonstrate that, in contrast to the current model that the absence of CD4+T cell help at priming results in long-term antibody nonresponsiveness, antibody responses can be induced by adenovirus vector immunization or alum-adjuvanted protein immunization even if CD4+T cell help is not provided until >1 month after immunization. These data demonstrate that the time when CD4+T cell help signals must be provided is more dynamic and flexible than previously appreciated. These data suggest that augmentation of CD4+T cell helper function even after the time of vaccination can enhance vaccine-elicited antibody responses and thereby potentially enhance the immunogenicity of vaccines in immunocompromised individuals.


AIDS ◽  
2014 ◽  
Vol 28 (17) ◽  
pp. 2495-2504 ◽  
Author(s):  
Genevieve Clutton ◽  
Alexei Carpov ◽  
Christopher L. Parks ◽  
Hansi J. Dean ◽  
David C. Montefiori ◽  
...  

2021 ◽  
Author(s):  
Simeng Lin ◽  
Nicholas Kennedy ◽  
Aamir Saifuddin ◽  
Diana Muñoz Sandoval ◽  
Catherine Reynolds ◽  
...  

Abstract To inform healthcare policy for immunosuppressed patients there is a need to define SARS-CoV-2 vaccine responses. Here we report SARS-CoV-2 vaccine-induced antibody and T cell responses in patients treated with anti-tumour necrosis factor (anti-TNF), a commonly used biologic in inflammatory diseases, compared to patients treated with vedolizumab, a gut-specific antibody targeting integrin a4b7 that does not impair systemic immunity. In anti-TNF recipients, the magnitude of anti-SARS-CoV2 antibodies was reduced five-fold, and rapidly decayed towards the seroconversion threshold by 14 weeks after second dose of vaccine. In contrast, anti-SARS-CoV-2 antibodies were sustained up to 16 weeks in vedolizumab-treated patients. Anti-SARS-CoV2 antibody decay was not observed in vaccinated patients previously infected with SARS-CoV-2. T cell responses were absent in one-fifth of anti-TNF and vedolizumab-treated patients after a second dose of either vaccine. Our data have important implications for anti-TNF recipients, including the need for vaccine prioritization, booster doses, and social distancing strategies.


2011 ◽  
Vol 209 (1) ◽  
pp. 157-171 ◽  
Author(s):  
De Yang ◽  
Yuri V. Postnikov ◽  
Yana Li ◽  
Poonam Tewary ◽  
Gonzalo de la Rosa ◽  
...  

Alarmins are endogenous mediators capable of promoting the recruitment and activation of antigen-presenting cells (APCs), including dendritic cells (DCs), that can potentially alert host defense against danger signals. However, the relevance of alarmins to the induction of adaptive immune responses remains to be demonstrated. In this study, we report the identification of HMGN1 (high-mobility group nucleosome-binding protein 1) as a novel alarmin and demonstrate that it contributes to the induction of antigen-specific immune responses. HMGN1 induced DC maturation via TLR4 (Toll-like receptor 4), recruitment of APCs at sites of injection, and activation of NF-κB and multiple mitogen-activated protein kinases in DCs. HMGN1 promoted antigen-specific immune response upon co-administration with antigens, and Hmgn1−/− mice developed greatly reduced antigen-specific antibody and T cell responses when immunized with antigens in the presence of lipopolysaccharide (LPS). The impaired ability of Hmgn1−/− mice to mount antigen-specific immune responses was accompanied by both deficient DC recruitment at sites of immunization and reduced production of inflammatory cytokines. Bone marrow chimera experiments revealed that HMGN1 derived from nonleukocytes was critical for the induction of antigen-specific antibody and T cell responses. Thus, extracellular HMGN1 acts as a novel alarmin critical for LPS-induced development of innate and adaptive immune responses.


2006 ◽  
Vol 36 (2) ◽  
pp. 287-295 ◽  
Author(s):  
Håvard Jakobsen ◽  
Solveig Hannesdottir ◽  
Stefania P. Bjarnarson ◽  
Dominique Schulz ◽  
Emanuelle Trannoy ◽  
...  

PLoS ONE ◽  
2010 ◽  
Vol 5 (2) ◽  
pp. e9015 ◽  
Author(s):  
Richard A. Koup ◽  
Mario Roederer ◽  
Laurie Lamoreaux ◽  
Jennifer Fischer ◽  
Laura Novik ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document